University of Patras
Ιn vitro διερεύνηση της ικανότητας στόχευσης του αιματεγκεφαλικού φραγμού και της αντικαρκινικής δράσης στοχευμένων πολυλειτουργικών μαγνητολιποσωμάτων που εγκλωβίζουν δοξορουβικίνη
Abstract
dc:descriptionMagnetoliposomes can provide platforms for simultaneously carrying therapeutics and diagnostics. The controlled optical properties of the magnetic nanoparticles combined with the versatility of liposomes as carriers can potentially enhance the efficacy of treatment for selective drug delivery by means of an external magnetically guided deposition and prolonged targeting by receptor-mediated activation (e.g., pegylation and surface modification: ligands and antibodies). Due to their optical properties, magnetic nanoparticles can serve as MRI contrast agents allowing their in vivo monitoring and distribution of the pharmaceuticals in a non-invasive way.The aim of this work was initially the formulation of magnetoliposomes, their physicochemical characterization and the impact of various factors on their physicochemical properties and stability.For the preparation of the MLs the initial target was the entrapment of the maximum concentration of USPIOs in small unilamellar vesicles, while retaining their size (<200nm) in order to exploit the effect of enhanced permeability and retention (EPR effect) presented by cancer cells. The DRV method (extruded), provided MLs with greater entrapment at the desired size. The addition of cholesterol to the ML had no significant effect on encapsulation, which applied also to the addition of negative charge (PG lipid), while addition of lipid PEG and higher initial ratios USPIOs / lipid increased the entrapment. Encapsulation of the USPIOs into liposomes led in a sharp increase of the magnetic response while higher Fe/Lipid ratio increased it even further. The same applied when 4mol% lipid-PEG was added or MLs size was increased, whereas addition of cholesterol reduced the response to the external magnetic field. USPIOs encapsulation also increased their ability as contrast agents, regardless lipid composition, addition of lipid PEG did not bring about any drastic change, while higher Fe/Lipid ratio led to an increase. MLs were stable long enough for use in in vivo applications and exhibited almost no cytotoxicity. Finally MLs were studied in vitro for their ability to cross the where it was found that in the presence of magnetic field, permeation increases up to 10 times, revealing the possibility offered by MLs to deliver drugs to the brain utilizing magnetic targeting.Next aim of this work was the formation of t-MLs for targeting the BBB. MLs decorated with either OX-26 antibody (targeting of the transferrin receptor) or the ApoE peptide (lipoprotein receptor targeting) or both were prepared and their effect on the physicochemical properties of MLs was studied. Decoration with one ligand had no significant effect on the entrapment or MLs’ size whilst a combination of 2 or 3 ligands lead to a slight decrease in the entrapment. Addition of an antibody on the MLs surface caused a slight reduction of the magnetophoretic ability of the MLs while this was the case also for their contrast agent ability. t-MLs were found to be stable for time sufficient enough for their administration and showed no cytotoxicity. In regards to their ability to cross the BBB, in vitro decoration with one ligand increased permeation of ML at least 5 times while decoration with two ligands had a cumulative effect, enhancing BBB permeation more than 10 times. These results demonstrate the ability of t-ML to target the BBB and their possible use as a diagnostic imaging tool of the brain.After the successful preparation of MLs and t-MLs that can be used for diagnosis, the next step was the preparation of MLs which combine their diagnostic capability with a therapeutic effect. To this end we investigated the preparation of MLs co-encapsulation USPIOs with doxorubicin, a molecule with anti-cancer activity. For the co-encapsulation of doxorubicin and USPIOs a combination of the DRV technique and active loading was utilized. The presence of USPIOs, the DOX / lipid ratio and the DOX / USPIOs ratio had almost no effect on doxorubicin encapsulation as neither had the decoration of MLs with an antibody. USPIOs-DOX co-encapsulation had no effect on the retention of doxorubicin and it’s release rate nor on the retention of USPIOs while MF-ML remained stable in the presence of serum proteins for sufficient time. Then the MF-ML prepared were studied in vitro for their antitumor activity in which the results showed that USPIOs co-encapsulation does not affect the antitumor activity of doxorubicin which is dose-dependent, the effect of magnetic field is Fe concentration-dependent, while dual targeting (passive via the magnetic field and active through the antibody) exhibited the highest antitumor activity.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Skouras, Athanasios
- Σκούρας, Αθανάσιος
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40646